Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Decreasing Function01:27

Decreasing Function

241
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
241
Decreased Body Temperature01:29

Decreased Body Temperature

1.0K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K
Decreased pulse rate01:14

Decreased pulse rate

858
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
858
Graded Potential01:19

Graded Potential

6.9K
Graded potentials are localized fluctuations in the cell membrane's electrical charge, commonly found in the dendrites of neurons. The magnitude of these potential changes depends on the strength of the initiating stimulus. In a membrane at its resting potential, a graded potential signifies a voltage shift either above -70 mV or below -70 mV.
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
6.9K
What is Metabolism?00:52

What is Metabolism?

131.4K
Overview
131.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upregulated GLUT1 expression correlates with type I interferon activity and disease severity in cutaneous lupus erythematosus.

Journal of translational autoimmunity·2026
Same author

From 2D to 3D Bioprinted In Vitro Breast Cancer Model: A Comparative Study of Proliferation, Tissue Structure, and mTOR Signaling.

MedComm·2026
Same author

3D bioprinted in vitro models in cancer metabolism research.

Magyar onkologia·2026
Same author

TSC gene-associated lesions of the lung.

Human pathology·2026
Same author

CD44 is critical for TLR4-mediated NLRP3 inflammasome activation and the development of bronchopulmonary dysplasia.

American journal of respiratory cell and molecular biology·2026
Same author

Sample adequacy in bronchoscopic ROSE: comparison between laboratory specialist and pathologist.

Pathology oncology research : POR·2026

Related Experiment Video

Updated: Jan 23, 2026

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.9K

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells.

Gábor Petővári1, Titanilla Dankó1, Ildikó Krencz1

  • 11st Department of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, Budapest, H-1085, Hungary.

Pathology Oncology Research : POR
|June 13, 2019
PubMed
Summary

Glioblastoma multiforme (GBM) exhibits metabolic heterogeneity, driving treatment resistance. Targeting multiple metabolic pathways, particularly mTORC2, offers promising combination therapy strategies for this aggressive brain cancer.

Keywords:
Combination therapyGliomaMetabolic shiftMetabolismmTORC2

More Related Videos

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.1K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.2K

Related Experiment Videos

Last Updated: Jan 23, 2026

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.9K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.1K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.2K

Area of Science:

  • Oncology
  • Neuroscience
  • Biochemistry

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain cancer with high recurrence and resistance to therapies.
  • Tumoral heterogeneity complicates treatment by masking resistant clones and adaptation mechanisms.
  • Existing therapies have not significantly improved patient survival rates.

Purpose of the Study:

  • To analyze the in situ metabolic heterogeneity of high-grade human glioblastoma.
  • To investigate the therapeutic potential of targeting metabolic pathways in glioma cell lines.
  • To evaluate combination therapies involving rapamycin and metabolic inhibitors.

Main Methods:

  • Immunohistochemistry on tissue microarrays to assess metabolic heterogeneity in GBM.
  • Protein expression analysis (Western blot, WES Simple) in glioma cell lines.
  • In vitro drug sensitivity assays (Alamar Blue, SRB) using temozolomide, metabolic inhibitors, and rapamycin.

Main Results:

  • Metabolic heterogeneity was observed in high-grade glioblastoma cases.
  • Enhanced Rictor expression correlated with lower sensitivity to monotherapies.
  • Combination therapies with rapamycin and other metabolic inhibitors showed efficacy, except for glutaminase inhibitors.

Conclusions:

  • Metabolic heterogeneity and treatment-induced shifts are critical in GBM.
  • Targeting multiple metabolic pathways, including mTORC2 components (Rictor, p-Akt, p-S6) and enzymes (CPT1A, LDHA), is a viable combination therapy strategy.
  • Mapping metabolic heterogeneity in biopsies is crucial for personalized glioblastoma treatment.